Literature DB >> 28422282

Analysis of Circulating miR-1, miR-23a, and miR-26a in Atrial Fibrillation Patients Undergoing Coronary Bypass Artery Grafting Surgery.

Andre Feldman1, Dalmo Antonio Ribeiro Moreira1, Carlos Gun1, Hui-Tzu Lin Wang1, Mario Hiroyuki Hirata, Juliana de Freitas Germano2, Gabriela Guimarães Sousa Leite2, Pedro Farsky1.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia after cardiac surgery. From a pathophysiological point of view, a myriad of factors such as trauma, atrial dilation, ischemia, mechanical myopericarditis, autonomic imbalance, loss of connexins, AF nest remodeling, inflammation, sutures, and dysfunction caused by postextracorporeal circulation can contribute to postoperative atrial fibrillation (POAF) resulting in a longer hospital stay and consequently higher cost. Recent studies showed that short fragments of RNA, called microRNA (miRNA), can contribute to the development of several cardiovascular diseases, including AF. The aim of this study was to evaluate the levels of circulating miRNAs (miR-1, -23a, and -26a) that can be involved in POAF. Patients submitted to coronary artery bypass graft surgery were grouped in POAF (24 patients) and without POAF (24 patients). Results showed older age, longer clamp-time, and more days in the intensive care unit as well as a longer total hospital stay in the POAF group. Preoperative levels of circulating miRNAs were similar. Analysis of miRNAs revealed significantly lower circulating levels of miRNA-23a (P  =  0.02) and -26a (P  =  0.01) in the POAF group during the postoperative period. Receiver operating characteristic (ROC) analysis showed the area under the ROC curve of miR-23a and miR-26a for predicting FA was 0.63 (95% confidence interval [CI]: 0.51-0.74; P  =  0.02) and 0.66 (95% CI: 0.55-0.77; P  =  0.01), respectively. Our data suggests that circulating miRNA-23a and -26a may be involved in the underlying biology of postoperative AF development.
© 2017 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  Coronary artery bypass graft surgery; postoperative atrial fibrillation and microRNA

Mesh:

Substances:

Year:  2017        PMID: 28422282     DOI: 10.1111/ahg.12188

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  16 in total

Review 1.  The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.

Authors:  Stępień E; Marina C Costa; Szczepan Kurc; Anna Drożdż; Nuno Cortez-Dias; Francisco J Enguita
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

2.  LncRNA MIAT/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis.

Authors:  Lixia Yao; Bolun Zhou; Ling You; Haijuan Hu; Ruiqin Xie
Journal:  Mol Biol Rep       Date:  2020-03-04       Impact factor: 2.316

3.  MicroRNA expression signatures of atrial fibrillation: The critical systematic review and bioinformatics analysis.

Authors:  Nan-Nan Shen; Chi Zhang; Zheng Li; Ling-Cong Kong; Xin-Hua Wang; Zhi-Chun Gu; Jia-Liang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-25

Review 4.  Leveraging Extracellular Non-coding RNAs to Diagnose and Treat Heart Diseases.

Authors:  Zhenyi Zhao; Ningning Guo; Weixin Chen; Zhihua Wang
Journal:  J Cardiovasc Transl Res       Date:  2022-04-13       Impact factor: 3.216

Review 5.  RNAs and Gene Expression Predicting Postoperative Atrial Fibrillation in Cardiac Surgery Patients Undergoing Coronary Artery Bypass Grafting.

Authors:  Muhammad Shuja Khan; Kennosuke Yamashita; Vikas Sharma; Ravi Ranjan; Derek James Dosdall
Journal:  J Clin Med       Date:  2020-04-16       Impact factor: 4.241

Review 6.  miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.

Authors:  Shan-Shan Zhou; Jing-Peng Jin; Ji-Qun Wang; Zhi-Guo Zhang; Jonathan H Freedman; Yang Zheng; Lu Cai
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

7.  Integrative Analysis of miRNA and mRNA Expression Profiles Associated With Human Atrial Aging.

Authors:  Yan Yao; Chenxi Jiang; Fan Wang; Han Yan; Deyong Long; Jinghua Zhao; Jiangang Wang; Chunxiao Zhang; Yang Li; Xiaoli Tian; Qing K Wang; Gang Wu; Zhihui Zhang
Journal:  Front Physiol       Date:  2019-09-19       Impact factor: 4.566

Review 8.  Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers.

Authors:  Kun Xiang; Muhammad Akram; Walaa Fikry Elbossaty; Jinfu Yang; Chengming Fan
Journal:  Heart Fail Rev       Date:  2021-07-12       Impact factor: 4.654

Review 9.  Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.

Authors:  Debora Cristina Pereira da Silva; Felipe Demani Carneiro; Kelly Costa de Almeida; Caroline Fernandes-Santos
Journal:  Arq Bras Cardiol       Date:  2018-11       Impact factor: 2.000

10.  The role of physical activity and miRNAs in the vascular aging and cardiac health of dialysis patients.

Authors:  Miroslava Rabajdova; Ivana Spakova; Aurel Zelko; Jaroslav Rosenberger; Peter Kolarcik; Vladimira Sobolova; Daniel Pella; Maria Marekova; Andrea Madarasova Geckova
Journal:  Physiol Rep       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.